Skip to Content

MYLAN A (Alprazolam 0.25 mg)

Pill imprint MYLAN A has been identified as Alprazolam 0.25 mg.

Alprazolam is used in the treatment of anxiety; panic disorder; depression; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Alprazolam 0.25 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Alprazolam 0.25 mg MYLAN A  Front
Alprazolam 0.25 mg MYLAN A  Back
Alprazolam 0.25 mg MYLAN A
0.25 mg
7.00 mm
Prescription only
Drug Class:
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
docusate sodium
lactose monohydrate
magnesium stearate
microcrystalline cellulose
sodium benzoate
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0788 UDL Laboratories Inc
49999-0039 Lake Erie Medical and Surgical Supply (repackager)
16590-0447 Stat RX USA LLC (repackager)
67544-0124 Prepak Systems Inc (repackager)
23490-5032 Palmetto State Pharmaceuticals Inc (repackager)
43063-0088 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.